A reagent and kit for determining global coagulability and hemostatic potential

Details for Australian Patent Application No. 2002215382 (hide)

Owner bioMerieux, Inc.

Inventors Baglin, Trevor; Luddington, Roger; Tejidor, Liliana; Fischer, Timothy J.; Doobay, Hema

Agent Pizzeys

Pub. Number AU-B-2002215382

PCT Pub. Number WO02/34109

Priority 09/698,589 27.10.00 US

Filing date 18 October 2001

Wipo publication date 6 May 2002

Acceptance publication date 24 November 2005

International Classifications

G01N 033/86 Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

C12Q 001/56 Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

C07K 004/00 Peptides having up to 20 amino acids in an undefined or only partially defined sequence

Event Publications

24 November 2005 Application Accepted

  Published as AU-B-2002215382

23 March 2006 Standard Patent Sealed

28 May 2009 Assignment Registered

  Biomerieux, Inc. The patent has been assigned to Cambridge University Hospitals NHS Foundation Trust

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002215383

2002215381-Circuit interrupting device